Background & Aims: In the general population, 24-h urine potassium excretion is considered the reference standard for estimating potassium intake. However, its agreement with food records and spot urine collections in adults living with chronic kidney disease (CKD) is not well-established. Given the risk of hyperkalemia related to changes in renal potassium handling, understanding if this reference standard is appropriate for the CKD population is important. This study aimed to compare agreement between methods for estimating potassium intake, using food records, 24-h urine measures, and spot urine samples.
Methods: A cross-sectional study was conducted among adults recruited from a kidney care clinic. Participants were instructed to complete a detailed food record and a 24-h urine collection, both performed on the same day. The following day, participants provided a spot urine sample from the second void, at the research site. Potassium excretion was estimated from the spot urine sample using Tanaka's and Kawasaki's equations. Agreement between methods was assessed using the highest p-value for paired t-test and the lowest Bland-Altman bias combined with the narrowest upper and lower limits of agreements (LoA).
Results: 60 adults with Stage 3 and 4 CKD completed the study (48 % male, 62.9 ± 14.6 years; eGFR = 34.9 ± 12.7 mL/min). The food records showed the highest agreement with 24-h urine potassium (1823.9 ± 746.7 vs 1918.2 ± 809.3, p = 0.584). This was followed by Kawasaki's equation for spot urine (1994.8 ± 441.9, p = 0.231) and Tanaka's equation (1630.0 ± 325.9, p = 0.174). Food records and Kawasaki's equation had slightly higher mean values compared to 24-h urine with mean differences <100-200 mg/day (bias; 95%CI: bias = -94.4 mg/day; -438.3 to 249.6 mg/day and -170.9 mg/day; -454.1 to 112.2 mg/day, respectively). Tanaka's equation had a lower mean value compared to 24-h urine with a mean difference of 193.9 mg/day; -88.5 to 476.3 mg/day). The limits of agreement were as follows: in the Kawasaki's equation from -2082.2 to 1740.3 mg/day, in the Tanaka's equation from -1712.2 to 2100.0 mg/day and in the food records from -2416.1 to 2227.4 mg/day.
Conclusion: Mean potassium intake estimates were similar across methods. Food records demonstrated the highest agreement with 24-h urine potassium, followed by Kawasaki's equation. The Tanaka's equation showed the highest bias compared to 24-h urine and was significantly different from food records. Combining food records with potassium excretion estimated using the Kawasaki's equation from spot urine samples may be a clinically useful tool for assessing potassium intake in adults with CKD.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.clnesp.2025.01.020 | DOI Listing |
Endocrine
January 2025
Department of Endocrinology and Metabolic Diseases, Manisa Celal Bayar University Hospital, Manisa, Turkey.
Purpose: Our study evaluated skeletal muscle mass, function and quality among mild autonomous cortisol secretion (MACS) patients and non-functioning adrenal incidentaloma (NFAI) patients in comparison with the control group without adrenal mass.
Methods: 63 NFAI (49 female, 14 male) and 31 MACS (24 female, 7 male) patients were included in the study. As the control group, 44 patients (31 women, 13 men) who were known to have no radiological adrenal pathology on computed tomography or magnetic resonance imaging performed for other reasons were selected.
Int J Environ Res Public Health
January 2025
Million Marker Wellness, Inc., Berkeley, CA 94704, USA.
Background: Daily-use products, including personal care products, household products, and dietary supplements, often contain ingredients that raise concerns regarding harmful chemical exposure. Endocrine-disrupting chemicals (EDCs) found in daily-use products are associated with numerous adverse health effects.
Methods: This pilot study explores the relationship between concentrations of EDCs in urine samples and products used 24 h prior to sample collection, and ingredients of concern in those products, in 140 adults of reproductive age in Northern Nevada.
Drug Test Anal
January 2025
Catalonian Antidoping Laboratory, Doping Control Research Group, Hospital del Mar Research Institute, Barcelona, Spain.
The detection of endogenous anabolic androgenic steroids (EAAS) is performed with the Steroidal Module of the Athlete Biological Passport (ABP). Glucocorticoids (GC) could be a confounding factor to the ABP Steroidal Module because they inhibit the hypothalamic-pituitary-adrenal axis, and ABP metabolites have partial adrenal origin. In previous studies, single-dose systemic GC administrations have been shown to reduce the urinary ratios A/T and 5αdiol/E.
View Article and Find Full Text PDFMetabolites
January 2025
Group of Authors on Behalf of the Transplant Lines Biobank and Cohort Study, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands.
: Pharmacogenomics (PGx) has revolutionized personalized medicine, notably by predicting drug responses through the study of the metabolic genotype of drug-metabolizing enzymes. However, these genotypes rely heavily on the availability and completeness of drug metabolism information and do not account for (all) "phenoconversion" factors, like drug-drug interactions and comorbidities. To address these limitations, a more phenotypic approach would be desirable, for which pharmacometabolomics (PMx) could be useful by studying and elucidating drug metabolism in patient samples, such as blood and urine.
View Article and Find Full Text PDFNat Rev Dis Primers
January 2025
Endocrine Division, Department of Medicine, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Québec, Canada.
Cushing syndrome (CS) is a constellation of signs and symptoms caused by excessive exposure to exogenous or endogenous glucocorticoid hormones. Endogenous CS is caused by increased cortisol production by one or both adrenal glands (adrenal CS) or by elevated adrenocorticotropic hormone (ACTH) secretion from a pituitary tumour (Cushing disease (CD)) or non-pituitary tumour (ectopic ACTH secretion), which stimulates excessive cortisol production. CS is associated with severe multisystem morbidity, including impaired cardiovascular and metabolic function, infections and neuropsychiatric disorders, which notably reduce quality of life.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!